EPISODE · Dec 17, 2025 · 41 MIN
Why Celebrity Brands Must Survive Without the Celebrity | Daniel Faierman, Habitat Partners
When Daniel Faierman first connected with Scott 3 years ago, he made one thing clear: he was skeptical about celebrity-founded brands. Fast forward to today, and the Habitat Partners investor has backed Ayo by Molly Baz, Sincerely Yours by Salish Matter, and Elm Biosciences by Martha Stewart. But here's the twist—his skepticism hasn't disappeared. Instead, Daniel has developed a ruthless framework for separating authentic innovation from celebrity hype, and his approach challenges everything most investors think they know about this booming category. In this episode, you'll discover: The morbid but essential question Daniel asks before every celebrity brand investment: "What happens if the celebrity dies tomorrow?" Why he believes access matters more than picking ability for early-stage investors—and how Habitat Partners built a unique vantage point through Red Antler's creative agency ecosystem The "celebrity friends with benefits" phenomenon that 10X's influencer marketing through network effects most founders never consider How Rhode's 9x marketing efficiency ratio (generating $9 for every $1 spent) reveals the hidden economic advantage of celebrity brands—and why it's attracting tech investors to CPG Why Daniel walked away from celebrity brands raising at $50M+ pre-launch valuations and the fundamental problem with paying premium multiples at entry The three critical variables that determine VC success: access, picking, and value-add—and why most funds get the priority order completely wrong How retailers like Target are now taking celebrity brands earlier than traditional startups—creating a distribution advantage that didn't exist five years ago Why high gross margin categories like condiments, sauces, and anti-aging serums are more attractive than low-margin plays—and how celebrity can't solve fundamental unit economics problems What makes a 15-year-old creator like Salish Matter fundamentally different from an 84-year-old icon like Martha Stewart—and how each brings distinct strategic value to their brands The "second wave" of celebrity brands that are product-first, not celebrity-first—and why formulation IP and technology moats are replacing white-label strategies His unfiltered take on due diligence: "Send me the co-manufacturing contracts—I want to back into gross margin before I even think about the celebrity" This information is for informational purposes only and is not a substitute for professional financial advice. Nothing discussed here constitutes investment, legal, or tax advice, and any decisions are your own responsibility. Investing involves risks, and past performance is not indicative of future results. Always consult with a qualified professional for advice tailored to your individual circumstances. Chapters: Chapters 00:00:26 Welcome and Introduction to Daniel Fairman 00:01:08 Daniel's Journey: From Big CPG to Venture Capital 00:03:47 The Habitat Partners Origin Story 00:07:47 What It Takes to Win in Early-Stage VC 00:10:17 From Skeptic to Investor: Shifting Perspective on Celebrity Brands 00:14:52 Deep Dive: Ayo by Molly Baz 00:17:33 Deep Dive: Sincerely Yours by Salish Matter 00:20:21 Deep Dive: Elm Biosciences by Martha Stewart 00:23:43 The Unique Advantages of Celebrity Founder Brands 00:27:04 The Risks and Red Flags of Celebrity Brands 00:28:57 Comparing Creator Types: Gen Alpha vs Established Celebrity 00:32:40 Due Diligence Framework for Celebrity Brands 00:34:13 The Valuation Problem: Premium Multiples at Entry vs Exit 00:36:20 Building Brand Through Content: The Term Sheet Pitfalls Newsletter 00:38:00 What's Next for Habitat Partners 00:39:40 Final Advice: The Celebrity Death Test 00:40:49 Closing and Where to Find Daniel HotStart VC Subscribe to the HotStart VC newsletter: https://hotstart.beehiiv.com/ Become a HotStart Angel and co-invest with us in celebrity-founded brands starting from $5,000: https://www.hotstart.vc/hotstart-angels/ Check out our fund: https://www.hotstart.vc/ Scott van den Berg LinkedIn: https://www.linkedin.com/in/scott-van-den-berg-22b534150/ Instagram: https://www.instagram.com/scottvandenberg_/ TikTok: https://www.tiktok.com/@scottvandenberg_ YouTube: https://www.youtube.com/@scottvandenbergvc Daniel Faierman Habitat Partners: https://www.habitatpartners.co/ LinkedIn: https://www.linkedin.com/in/danielfairman/ Term Sheet Pitfalls Newsletter: https://termsheetpitfalls.substack.com/ HotStart VC is a fund that exclusively invests in brands founded by celebrities and creators. We're the go-to platform for celebrities and creators launching brands, providing capital, strategic support, and the infrastructure to scale.
What this episode covers
When Daniel Faierman first connected with Scott 3 years ago, he made one thing clear: he was skeptical about celebrity-founded brands. Fast forward to today, and the Habitat Partners investor has backed Ayo by Molly Baz, Sincerely Yours by Salish Matter, and Elm Biosciences by Martha Stewart. But here's the twist—his skepticism hasn't disappeared. Instead, Daniel has developed a ruthless framework for separating authentic innovation from celebrity hype, and his approach challenges everything most investors think they know about this booming category. In this episode, you'll discover: The morbid but essential question Daniel asks before every celebrity brand investment: "What happens if the celebrity dies tomorrow?" Why he believes access matters more than picking ability for early-stage investors—and how Habitat Partners built a unique vantage point through Red Antler's creative agency ecosystem The "celebrity friends with benefits" phenomenon that 10X's influencer marketing through network effects most founders never consider How Rhode's 9x marketing efficiency ratio (generating $9 for every $1 spent) reveals the hidden economic advantage of celebrity brands—and why it's attracting tech investors to CPG Why Daniel walked away from celebrity brands raising at $50M+ pre-launch valuations and the fundamental problem with paying premium multiples at entry The three critical variables that determine VC success: access, picking, and value-add—and why most funds get the priority order completely wrong How retailers like Target are now taking celebrity brands earlier than traditional startups—creating a distribution advantage that didn't exist five years ago Why high gross margin categories like condiments, sauces, and anti-aging serums are more attractive than low-margin plays—and how celebrity can't solve fundamental unit economics problems What makes a 15-year-old creator like Salish Matter fundamentally different from an 84-year-old icon like Martha Stewart—and how each brings distinct strategic value to their brands The "second wave" of celebrity brands that are product-first, not celebrity-first—and why formulation IP and technology moats are replacing white-label strategies His unfiltered take on due diligence: "Send me the co-manufacturing contracts—I want to back into gross margin before I even think about the celebrity" This information is for informational purposes only and is not a substitute for professional financial advice. Nothing discussed here constitutes investment, legal, or tax advice, and any decisions are your own responsibility. Investing involves risks, and past performance is not indicative of future results. Always consult with a qualified professional for advice tailored to your individual circumstances. Chapters: Chapters 00:00:26 Welcome and Introduction to Daniel Fairman 00:01:08 Daniel's Journey: From Big CPG to Venture Capital 00:03:47 The Habitat Partners Origin Story 00:07:47 What It Takes to Win in Early-Stage VC 00:10:17 From Skeptic to Investor: Shifting Perspective on Celebrity Brands 00:14:52 Deep Dive: Ayo by Molly Baz 00:17:33 Deep Dive: Sincerely Yours by Salish Matter 00:20:21 Deep Dive: Elm Biosciences by Martha Stewart 00:23:43 The Unique Advantages of Celebrity Founder Brands 00:27:04 The Risks and Red Flags of Celebrity Brands 00:28:57 Comparing Creator Types: Gen Alpha vs Established Celebrity 00:32:40 Due Diligence Framework for Celebrity Brands 00:34:13 The Valuation Problem: Premium Multiples at Entry vs Exit 00:36:20 Building Brand Through Content: The Term Sheet Pitfalls Newsletter 00:38:00 What's Next for Habitat Partners 00:39:40 Final Advice: The Celebrity Death Test 00:40:49 Closing and Where to Find Daniel HotStart VC Subscribe to the HotStart VC newsletter: https://hotstart.beehiiv.com/ Become a HotStart Angel and co-invest with us in celebrity-founded brands starting from $5,000: https://www.hotstart.vc/hotstart-angels/ Check out our fund: https://www.hotstart.vc/ Scott van den Berg LinkedIn: https://www.linkedin.com/in/scott-van-den-berg-22b534150/ Instagram: https://www.instagram.com/scottvandenberg_/ TikTok: https://www.tiktok.com/@scottvandenberg_ YouTube: https://www.youtube.com/@scottvandenbergvc Daniel Faierman Habitat Partners: https://www.habitatpartners.co/ LinkedIn: https://www.linkedin.com/in/danielfairman/ Term Sheet Pitfalls Newsletter: https://termsheetpitfalls.substack.com/ HotStart VC is a fund that exclusively invests in brands founded by celebrities and creators. We're the go-to platform for celebrities and creators launching brands, providing capital, strategic support, and the infrastructure to scale.
NOW PLAYING
Why Celebrity Brands Must Survive Without the Celebrity | Daniel Faierman, Habitat Partners
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m